Dr. Kristian Galanti | Genetics and Molecular Biology | Best Researcher Award
Medico Specializzando at Università degli Studi G. D’Annunzio di Chieti-Pescara | Italy
Dr. Kristian Galanti is a dedicated Resident Doctor in Cardiovascular Diseases and a PhD candidate in Medical Biotechnologies at the University G. D’Annunzio of Chieti-Pescara. He currently serves as a Research Fellow at the Center for Inherited Cardiovascular Disease, WellSpan Health, USA. His clinical interests include heart failure, cardiomyopathies, and cardiovascular imaging. Dr. Galanti demonstrates exceptional commitment to evidence-based care, contributing to both patient management and research. Known for his strong collaborative ethos, he has been actively involved in multidisciplinary case presentations, cardiovascular imaging, and the development of aetiology-oriented diagnostics in cardiology.
Profile:
Education
Dr. Kristian Galanti’s academic journey began with a Master’s Degree in Medicine and Surgery from the Catholic University of the Sacred Heart, Rome, graduating with professional qualification. He undertook further specialization in Cardiovascular Diseases at the University G. D’Annunzio of Chieti-Pescara and is currently pursuing a PhD in Medical Biotechnologies with a focus on technological innovation in cardiovascular sciences. His education is enriched with certifications in cardiac magnetic resonance, echocardiography, and cardiogenetic imaging from leading Italian and European cardiology societies, highlighting his pursuit of continuous learning and academic excellence in clinical and translational cardiology.
Experience:
Dr. Kristian Galanti has significant clinical and research experience. As a resident physician, he managed cardiology cases, conducted ECGs, and performed advanced imaging techniques including echocardiograms and cardiac MRIs. He also participated in interventional procedures, such as angioplasties and device implantations. At WellSpan Health, he contributes to inherited cardiovascular disease research, integrating imaging and genetics to understand arrhythmogenic mitral valve prolapse. He actively engages in writing scientific articles, producing scientific illustrations, and collaborating in multinational studies, making his dual expertise in clinical and research environments a rare and impactful combination.
Research Interest:
Dr. Kristian Galanti’s research centers on cardiovascular imaging, heart failure, and genetic cardiomyopathies. He is particularly focused on multimodality cardiovascular imaging (CMR, echo) and its correlation with genetic markers in diseases like dilated cardiomyopathy and mitral valve prolapse. His current projects involve imaging-genetics integration for arrhythmic risk stratification. Dr. Galanti is also engaged in drug interaction studies related to novel heart failure therapies. Through systematic reviews and original investigations, his work aims to bridge diagnostic precision with therapeutic personalization, making significant contributions to cardiogenetics and translational cardiovascular science.
Awards and Honors:
Dr. Kristian Galanti has earned several accolades for his academic and research contributions. He received the Italian Society of Cardiology Research Grant for excellence in cardiovascular science. Additionally, he was honored with the “Aldo Prosperini” Award for his original research on ejection fraction evaluation. he won the Best Poster Award at the ANMCO MUMA Congress for his clinical case on Cori-Forbes disease. Previous honors include the Clinical Case Award and Best Abstract Award from the Italian Society of Cardiology, along with the prestigious “Iginio Betti” Foundation Scholarship.
Publications:
Title: Diagnosis and management of dilated cardiomyopathy: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Citation: 20
year of Publications: 2024
Title: Arrhythmogenic Cardiomyopathy: Diagnosis and Management
Citation: 18
year of Publications: 2025
Title: Managing drug–drug interactions with mavacamten: a practical guide for clinicians
Citation: 15
year of Publications: 2024
Title: Arrhythmogenic mitral valve prolapse: from clinical features to imaging and genetics
Citation: 10
year of Publications: 2024
Title: Left ventricular non-compaction cardiomyopathy and related phenotypes: diagnosis, prognosis and treatment
Citation: 9
year of Publications: 2025
Title: Current antithrombotic treatments in heart failure: a review
Citation: 7
year of Publications: 2024
Title: Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics
Citation: 1
year of Publications: 2024
Conclusion:
Dr. Kristian Galanti exemplifies the ideal nominee for a Best Researcher Award. With a solid foundation in clinical cardiology and a progressive academic track in cardiovascular biotechnologies, he combines precision medicine, imaging innovation, and genetic insights in his work. His publication record, international research fellowships, and prestigious recognitions reflect his role as a rising leader in cardiovascular research. Dr. Galanti’s commitment to collaborative science, continual learning, and impactful patient care affirms his readiness to shape the future of cardiovascular medicine with compassion, innovation, and academic rigor.